Aura Biosciences Inc reports results for the quarter ended in January - Earnings Summary

Aura Biosciences

08/08/2024 13:19

* Aura Biosciences Inc  AURA.OQ  reported a quarterly
adjusted
loss of 41 cents​​ per share for the quarter ended in January,
higher than the same quarter last year, when the company
reported EPS of -48 cents.  The mean expectation of six analysts
for the quarter was for a loss of 45 cents per share. Wall
Street expected results to range from -47 cents to -42 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aura Biosciences Inc's reported EPS for the quarter was a
loss
of 41 cents​.
    * The company reported a quarterly loss of $20.34 million.
    * Aura Biosciences Inc shares had risen by 8.3% this
quarter and
lost 7.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aura Biosciences
Inc is $20.00 
This summary was machine generated from LSEG data August 8 at
12:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.45          -0.41          Beat
 Mar. 31 2024      -0.49          -0.40          Beat
 Dec. 31 2023      -0.41          -0.56          Missed
 Sep. 30 2023      -0.52          -0.48          Beat